YS Biopharma Reports Q1 Net loss Of $(9.6)M, Total Revenues Of $24.4M, Down 14.2% Y/Y
Portfolio Pulse from Benzinga Newsdesk
YS Biopharma reported a Q1 net loss of $9.6 million, with total revenues of $24.4 million, marking a 14.2% decrease year-over-year.
August 15, 2023 | 9:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
YS Biopharma reported a Q1 net loss of $9.6 million and a 14.2% decrease in total revenues year-over-year.
YS Biopharma's Q1 report shows a net loss and a significant decrease in revenues compared to the previous year. This could negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100